《Clinical Colorectal Cancer》重点专注发布医学-肿瘤学领域的新研究，旨在促进和传播该领域相关的新技术和新知识。鼓励该领域研究者详细地发表他们的高质量实验研究和理论结果。该杂志创刊至今，在医学-肿瘤学领域，有较高影响力，对来稿文章质量要求较高，稿件投稿过审难度较大。欢迎广大同领域研究者投稿该杂志。
| CiteScore | SJR | SNIP | CiteScore排名 | |||
|---|---|---|---|---|---|---|
| 5.5 | 1.336 | 0.842 | 学科类别 | 分区 | 排名 | 百分位 |
|
大类：大类：Medicine
小类：小类：Gastroenterology
|
Q2 | 47/167 | 72% | |||
|
大类：大类：Medicine
小类：小类：Oncology
|
Q2 | 146/404 | 63% | |||
| 按JIF指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
|---|---|---|---|---|
| 学科：ONCOLOGY | SCIE | Q2 | 118 / 322 | 63.5% |
| 按JCI指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
|---|---|---|---|---|
| 学科：ONCOLOGY | SCIE | Q2 | 151 / 322 | 53.26% |
文章名称
引用次数
Total Neoadjuvant Therapy: A Shifting Paradigm in Locally Advanced Rectal Cancer Management
25
A Comparison of Regorafenib and TAS-102 for Metastatic Colorectal Cancer: A Systematic Review and Network Meta-analysis
21
Optimal Interval to Surgery After Neoadjuvant Chemoradiotherapy in Rectal Cancer: A Systematic Review and Meta-analysis
16
Treatment and Survival Outcome of BRAF-Mutated Metastatic Colorectal Cancer: A Retrospective Matched Case-Control Study
13
Rising Proportion of Young Individuals With Rectal and Colon Cancer
13
A Review on the Scope of Photothermal Therapy-Based Nanomedicines in Preclinical Models of Colorectal Cancer
13
A Multicenter Clinical Phase II Study of FOLFOXIRI Plus Bevacizumab as First-line Therapy in Patients With Metastatic Colorectal Cancer: QUATTRO Study
13
Cost-effectiveness Analysis of Regorafenib and TAS-102 in Refractory Metastatic Colorectal Cancer in the United States
12
Recent Advances in the Clinical Development of Immune Checkpoint Blockade Therapy for Mismatch Repair Proficient (pMMR)/non-MSI-H Metastatic Colorectal Cancer
12
c-MET Overexpression in Colorectal Cancer: A Poor Prognostic Factor for Survival
11
国家/地区
发文量
TUSA
97
TItaly
45
TFrance
27
TCanada
26
TJapan
23
TEngland
20
TGERMANY (FED REP GER)
18
TSouth Korea
17
TCHINA MAINLAND
16
TBelgium
14
